Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial.
- DOI
- 10.1016/j.eclinm.2021.100959
- Published
- 2021-06-18
- Container
- EClinicalMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2021.100959,
title = {Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial.},
author = {Krolewiecki A and Lifschitz A and Moragas M and Travacio M and Valentini R and Alonso DF and Solari R and Tinelli MA and Cimino RO and Álvarez L and Fleitas PE and Ceballos L and Golemba M and Fernández F and Fernández de Oliveira D and Astudillo G and Baeck I and Farina J and Cardama GA and Mangano A and Spitzer E and Gold S and Lanusse C.},
year = {2021},
journal = {EClinicalMedicine},
doi = {10.1016/j.eclinm.2021.100959},
url = {https://doi.org/10.1016/j.eclinm.2021.100959}
}RIS
TY - JOUR TI - Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial. AU - Krolewiecki A AU - Lifschitz A AU - Moragas M AU - Travacio M AU - Valentini R AU - Alonso DF AU - Solari R AU - Tinelli MA AU - Cimino RO AU - Álvarez L AU - Fleitas PE AU - Ceballos L AU - Golemba M AU - Fernández F AU - Fernández de Oliveira D AU - Astudillo G AU - Baeck I AU - Farina J AU - Cardama GA AU - Mangano A AU - Spitzer E AU - Gold S AU - Lanusse C. PY - 2021 JO - EClinicalMedicine DO - 10.1016/j.eclinm.2021.100959 UR - https://doi.org/10.1016/j.eclinm.2021.100959 ER -
APA
A, K., A, L., M, M., M, T., R, V., DF, A., R, S., MA, T., RO, C., L, Á., PE, F., L, C., M, G., F, F., D, F. D. O., G, A., I, B., J, F., GA, C., A, M., E, S., S, G., & C., L. (2021). Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2021.100959
Source records
- europe-pmc · retrieved 2026-09-26T18:21:40.198Z
- doaj · retrieved 2026-09-26T18:21:40.191Z